Shanghai Accounts Payable from 2010 to 2025

688217 Stock   19.59  0.26  1.31%   
Shanghai Rightongene's Accounts Payable is increasing over the years with very volatile fluctuation. Overall, Accounts Payable is expected to go to about 24.5 M this year. Accounts Payable is the amount Shanghai Rightongene Biotechnology owes to suppliers or vendors for products or services received but not yet paid for. It represents Shanghai Rightongene's short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2010-12-31
Previous Quarter
16.5 M
Current Value
24.5 M
Quarterly Volatility
8.8 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Shanghai Rightongene financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Shanghai Rightongene's main balance sheet or income statement drivers, such as Net Interest Income of 2.2 M, Interest Income of 2.8 M or Interest Expense of 1 M, as well as many indicators such as . Shanghai financial statements analysis is a perfect complement when working with Shanghai Rightongene Valuation or Volatility modules.
  
This module can also supplement various Shanghai Rightongene Technical models . Check out the analysis of Shanghai Rightongene Correlation against competitors.

Currently Active Assets on Macroaxis

Other Information on Investing in Shanghai Stock

Shanghai Rightongene financial ratios help investors to determine whether Shanghai Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shanghai with respect to the benefits of owning Shanghai Rightongene security.